Symptomatic cases of COVID-19 fell 94 percent after two doses of the Pfizer vaccine, according to a new study.
Israel’s largest health provider, Clalit, analyzed data from more than 600,000 people in what is believed to be the country’s largest study to date.
The study also found that people were 92% less likely to develop serious illnesses caused by the virus with inoculations.
“This shows unequivocally that the Pfizer coronavirus vaccine is extremely effective in the real world a week after the second dose, just as it was discovered in the clinical study,” said Ran Balicer, director of innovation at Clalit.
The injection becomes even more effective two or more weeks after the second dose, said Balicer.
Researchers at the Weizmann Institute of Science also reported on Sunday that there was a significant decline for the first time in hospitalizations and serious illnesses with Israelis aged 55 and over.
The first age group to be vaccinated in the country were people aged 60 or over.
Wired Poles